medigraphic.com
SPANISH

Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello

ISSN 2539-0859 (Electronic)
ISSN 0120-8411 (Print)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

Acta de Otorrinolaringología CCC 2022; 50 (1)

Characterization of patients with abnormal neonatal hearing screening at the San Rafael Clinical University Hospital during the years 2018-2020

Macías-Tolosa C, Guzmán L, Gómez ÁN, Paredes ADX, Martínez H
Full text How to cite this article

Language: Spanish
References: 25
Page: 51-57
PDF size: 333.65 Kb.


Key words:

Hearing loss, neonatal screening, auditory evoked potentials.

ABSTRACT

Introduction: Neonatal hearing loss (NHL) is a relevant health problem due to its high incidence and the effects it may have both on the mental and psychological development of the patient. Neonatal hearing screening (NHS) is essential for the identification of patients at risk of NHL. Objective: To identify the characteristics of patients with abnormal NHS test results at the Hospital Universitario Clínica San Rafael. Design: Cross-sectional descriptive observational study. Materials and methods: Biological and clinical characteristics were identified in patients with abnormal otoacoustic emissions and/or auditory evoked potentials (AEP) performed between 2018 and 2020. Patients involved were divided into 2 groups according to the presence of risk factors for NHL. Results: 9027 patients were screened, 223 (2,47%) had abnormal results, but 19 patients were excluded. 204 patients were included in total, 46 (22.5%) of which were high risk (HR) and 158 (77.5%) were low risk (LR). NHS in LR patients was performed before the first month of life on 78.5% of cases and 21.4% of HR patients. The most frequent characteristics were mechanical ventilation (45.6%), intensive care unit admission (43.5%), craniofacial abnormality (15.2%) and hyperbilirubinemia greater than 20 mg/dL (10.8%). Conclusion: Efforts and resources should be optimized as means to perform hearing screening tests before the first month of life on 100% of patients. Complementary studies should be performed with the aim to identify the final auditory diagnoses of patients with abnormal results, as well as the type of treatment and auditory rehabilitation offered.


REFERENCES

  1. Cianfrone F, Mammarella F, Ralli M, Evetovic V, PianuraCM, Bellocchi G. Universal newborn hearing screening usingA-TEOAE and A-ABR: The experience of a large publichospital. J Neonatal Perinatal Med. 2018;11(1):87-92. doi:10.3233/NPM-181744.

  2. Saki N, Bayat A, Hoseinabadi R, Nikakhlagh S, Karimi M,Dashti R. Universal newborn hearing screening in southwesternIran. Int J Pediatr Otorhinolaryngol. 2017;97:89-92. doi:10.1016/j.ijporl.2017.03.038.

  3. Ngui LX, Tang IP, Prepageran N, Lai ZW. Comparisonof distortion product otoacoustic emission (DPOAE) andautomated auditory brainstem response (AABR) for neonatalhearing screening in a hospital with high delivery rate. Int JPediatr Otorhinolaryngol. 2019;120:184-8. doi: 10.1016/j.ijporl.2019.02.045.

  4. Dedhia K, Graham E, Park A. Hearing loss and failed newbornhearing screen. Clin Perinatol. 2018;45(4):629-43. doi:10.1016/j.clp.2018.07.004.

  5. Departamento Administrativo Nacional de Estadística. CensoGeneral 2005: nivel nacional. [en línea]. Disponible en: http://www.dane.gov.co (nota del revisor: el link debe ser directo aldocumento)

  6. INSOR. Estudio de percepción de la población sorda frenteal acceso a servicios. Bogotá: Observatorio Social PoblaciónSorda Colombiana. 2009.

  7. Rojas-Godoy A, Gomez-Gomez O, Rivas-Muñoz F.Cumplimiento de la normatividad vigente para la deteccióntemprana de la hipoacusia neonatal. Rev Salud Púb.2014;16(3):462-9. doi: 10.15446/rsap.v16n3.29149.

  8. Wenjin W, Xiangrong T, Yun L, Jingrong L, Jianyong C, XuelingW, et al. Neonatal hearing screening in remote areas of China:a comparison between rural and urban populations. J Int MedRes. 2018;46(2):637-51. doi: 10.1177/0300060517706643.

  9. American Academy of Pediatrics, Joint Committee onInfant Hearing. Year 2007 position statement: Principlesand guidelines for early hearing detection and interventionprograms. Pediatrics. 2007;120(4):898-921. doi: 10.1542/peds.2007-2333.

  10. Ministerio de Salud y Protección Social. Ley No. 1980 del 26de julio de 2019. Disponible en: https://www.minsalud.gov.co/Normatividad_Nuevo/Ley%201980%20de%202019.pdf

  11. Kanji A, Khoza-Shangase K. Objective Hearing ScreeningMeasures: An Exploration of a Suitable Combination forRisk-Based Newborn Hearing Screening. J Am Acad Audiol.2018;29(6):495-502. doi: 10.3766/jaaa.16155.

  12. Yee-Arellano HM, Leal-Garza F, Pauli-Müller K. Universalnewborn hearing screening in Mexico: results of the first 2years. Int J Pediatr Otorhinolaryngol. 2006;70(11):1863-70.doi: 10.1016/j.ijporl.2006.06.008.

  13. Kanji A, Khoza-Shangase K, Moroe N. Newborn hearingscreening protocols and their outcomes: A systematic review. IntJ Pediatr Otorhinolaryngol. 2018;115:104-109. doi: 10.1016/j.ijporl.2018.09.026.

  14. Thomas MSC, Johnson MH. New advances in understandingsensitive periods in brain development. Curr Dir Psychol Sci.2008;17(1):1-5. doi: 10.1111/j.1467-8721.2008.00537.x.

  15. Pimperton H, Blythe H, Kreppner J, Mahon M, Peacock JL,Stevenson J, et al. The impact of universal newborn hearingscreening on long-term literacy outcomes: a prospectivecohort study. Arch Dis Child. 2016;101(1):9-15. doi: 10.1136/archdischild-2014-307516.

  16. Joint Committee on Infant Hearing. Year 2019 positionstatement: principles and guidelines for early hearing detectionand intervention programs. J Early Hear Detect Interv.2019;4(2):1-44. doi: 10.15142/fptk-b748.

  17. Wroblewska-Seniuk K, Dabrowski P, Greczka G, SzabatowskaK, Glowacka A, Szyfter W, et al. Sensorineural and conductivehearing loss in infants diagnosed in the program of universalnewborn hearing screening. Int J Pediatr Otorhinolaryngol.2018;105:181-6. doi: 10.1016/j.ijporl.2017.12.007.

  18. Izquierdo JC, Muñetones N, Jiménez AP, Zea M, MuñozZ, León DA, et al. Prevalencia de alteraciones auditivasdetectadas mediante tamizaje en recién nacidos con factores deriesgo en la Unidad Neonatal del Hospital de San José. ActaOtorrinolaringol Cir Cabeza Cuello. 2013;41(2):111-6. doi:10.37076/acorl.v41i2.178.

  19. Vohr BR, Widen JE, Cone-Wesson B, Sininger YS, GorgaMP, Folsom RC, et al. Identification of neonatal hearingimpairment: Characteristics of infants in the neonatal intensivecare unit and well-baby nursery. Ear Hear. 2000;21(5):373-82.doi: 10.1097/00003446-200010000-00005.

  20. Chang J, Oh SH, Park SK. Comparison of newborn hearingscreening results between well babies and neonates admitted tothe neonatal intensive care unit for more than 5 days: Analysisbased on the national database in Korea for 9 years. PLoS One.2020;15(6):e0235019. doi: 10.1371/journal.pone.0235019.

  21. Lima GM, Marba ST, Santos MF. Hearing screening in aneonatal intensive care unit. J Pediatr (Rio J). 2006;82(2):110-4. doi: 10.2223/JPED.1457.

  22. De Leenheer EM, Janssens S, Padalko E, Loose D, LeroyBP, Dhooge IJ. Etiological diagnosis in the hearing impairednewborn: proposal of a flow chart. Int J Pediatr Otorhinolaryngol.2011;75(1):27-32. doi: 10.1016/j.ijporl.2010.05.040.

  23. Martínez-Cruz CF, García Alonso-Themann P, Poblano A,Cedillo-Rodríguez IA. Hearing and neurological impairmentin children with history of exchange transfusion for neonatalhyperbilirubinemia. Int J Pediatr. 2014;2014:605828. doi:10.1155/2014/605828.

  24. Olds C, Oghalai JS. Audiologic impairment associated withbilirubin-induced neurologic damage. Semin Fetal NeonatalMed. 2015;20(1):42-6. doi: 10.1016/j.siny.2014.12.006.

  25. Barreiro SB, Gonzalez JCF, Acosta AO, Macias AR. Hearingloss and very low birthweight. J Hear Sci. 2015;5(3):19-24.doi:10.17430/895172.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta de Otorrinolaringología CCC. 2022;50